The Clinical Development and Operations team at Blueprint Medicines is responsible for designing and executing clinical trials to evaluate the safety and efficacy of therapies for patients with genomically defined diseases. This team collaborates closely with regulatory affairs and biostatistics to ensure compliance and robust data analysis, while also managing drug safety and pharmacovigilance operations. Their ultimate goal is to expedite the development of innovative treatments by integrating clinical insights and operational excellence.
Elisabeth Garrison
Associate Director, Global Reg...
Ethel Holtzclaw
Director, Global Regulatory Sc...
Hongliang Shi
Director Of Biostatistics
Jennifer Sandidge
Director, Global Regulatory Sc...
Maria Roche
Vice President Clinical Develo...
Megan Foley
Director, Global Regulatory Sc...
Michael Scott Mulhol...
Associate Director, Global Reg...
Mikael Rinne
Vice President Of Clinical Dev...
Min Chen
Associate Director, Biostatist...
Shuree Harrison
Vice President, Clinical Opera...
View all